HomePER • ASX
add
Percheron Therapeutics Ltd
Previous close
$0.074
Day range
$0.074 - $0.077
Year range
$0.052 - $0.14
Market cap
81.11M AUD
Avg Volume
4.50M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 884.04K | 20.16% |
Operating expense | 4.46M | 17.84% |
Net income | -3.59M | -17.51% |
Net profit margin | -405.86 | 2.21% |
Earnings per share | — | — |
EBITDA | -3.58M | -17.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.87M | 8.20% |
Total assets | 14.53M | 13.14% |
Total liabilities | 5.17M | 80.21% |
Total equity | 9.36M | — |
Shares outstanding | 901.54M | — |
Price to book | 7.40 | — |
Return on assets | -61.71% | — |
Return on capital | -95.35% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -3.59M | -17.51% |
Cash from operations | -2.68M | 4.21% |
Cash from investing | 1.49K | 145.32% |
Cash from financing | 20.29K | 193.80% |
Net change in cash | -2.66M | 5.82% |
Free cash flow | -2.18M | -16.30% |
About
CEO
Founded
2000
Headquarters
Website
Employees
8
